Skip to content

A.forall Group

Group · 9 companies · 2 countries

A.forall Group and the 8 companies it controls according to the LEI register and the annual accounts: the structure, the figures, each company's health and where the risk sits.

Companies
9
8 in Belgium, 1 abroad
Countries
2
Belgium, Ireland
Total assets
€276.1m
what the companies own together
Equity
€204.4m
the shareholders' buffer
Net result
-€652,591
profit or loss of the year
Staff (FTE)
51.1
in Belgium, social balance

Sum of the filed annual accounts of 8 of the 8 Belgian companies (fiscal years 2024-2025). Not a consolidation: receivables, participations and sales between group companies are not eliminated, so they count.

A.forall Group also files consolidated accounts (fiscal year 2024): the real group figures, with intra-group positions eliminated. Checked does not read their figures yet; the document is at the National Bank's Central Balance Sheet Office.

Group risk

How healthy the group's Belgian companies are, and where the risk sits. A weak subsidiary can cost the parent money, and the other way round.

61/100 median score
  • The parent itself: A.forall Group, no verdict.
  • 1 company with negative equity: PI PHARMA (-€336,389).
  • 2 companies with a loss in the latest year: A.forall Group (-€16.1m), MEDIGROUP (-€201,774).
  • 56.7% of the added-up total assets sits in one company: A.forall Group.
  • 2.8% of the added-up total assets sits at companies with an elevated or high risk.

Group structure

Who consolidates whom according to the LEI register, completed with who holds more than half of the shares according to the annual accounts. Both mean control.

  • A.forall Group3 subsidiaries
    BE 0684.777.042Parent
    No verdict€156.6m €127.0m 2024
    • BE 0827.869.165100% per the accounts
      No verdict€61.2m €39.3m 2024
      • BE 0445.922.856LEI lapsed
        Healthy · 83€15.2m €11.7m 2024
    • MEDIGROUP4 subsidiaries
      BE 0826.773.857100% per the accounts
      Healthy · 62€30.2m €23.7m 2025
      • BE 0543.602.945100% per the accounts
        Elevated · 43€2.9m €497,064 2024
      • BE 0453.405.120100% per the accounts
        Healthy · 78€535,377 €394,601 2024
      • BE 0477.407.472100% per the accounts
        Healthy · 60€4.8m €2.3m 2024
      • BE 0883.315.652100% per the accounts
        Elevated · 44€4.8m -€336,389 2024
    • BETA ACTIVE PI PHARMA LIMITED
      IE Balbriggan, IrelandLEI lapsed

High risk Elevated Healthy Fair No verdict Amounts: total assets and equity from the latest accounts.

Events in the group

Bankruptcies, director changes, capital changes and other publications of all Belgian group companies, over the last two years.

  1. 1 director appointed, 1 director resigning
    Director changeIMPEXECO
  2. 1 director appointed, 1 director resigning
  3. 1 director appointed, 1 director resigning
    Director changeECO.PHARMA.SUPPLY
  4. 1 director appointed, 1 director resigning
    Director changeMEDIGROUP
  5. 1 director appointed, 1 director resigning
    Director changePI PHARMA

What is my exposure to this group?

The companies of this group you keep in your lists or follow, seen together.

Where do these figures come from?

Completed with the annual accounts: a company of which another Belgian company holds more than half of the shares, by the list of holdings or the shareholder structure in its accounts, stands under that company, with the share. The register of ultimate beneficial owners (UBO) is not public.

The group's make-up comes from the LEI register (GLEIF): which company consolidates which other, directly or ultimately. A company whose link the register does not state is not listed here, even if it does belong to the group.

The amounts are those of the annual accounts each Belgian company filed with the National Bank, added up without consolidation. The verdict per company is that of its dossier on Checked.be. Everything is updated every night.

Updated on 27-09-2026